GAJARSA, Circuit Judge. Teva Pharmaceuticals USA, Inc. (“Teva”) appeals the final judgment of the United States District Court of Delaware, which, after a bench trial, found Merck Co.’s (“Merck”) U.S. Patent No. 5,994,329 (issued Nov. 30, 1999) (“the ’329 patent”) *1366 not invalid as anticipated or obvious. The district c…
Read the full opinion (source) ↗
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Citation figures are counts of later citing opinions in our corpus and may be incomplete; always read and Shepardize the full opinion before relying on it.